It's high time for the scholarly societies to standardize the bronchodilator responsiveness in children

Main Article Content

Helmi Ben Saad

Keywords

ATS/ERS, bronchodilator reversibility, FEV1, FVC, GINA, spirometry

Abstract

Letter to the editor re: Mallol J, Riquelme C, Aguirre V, Martinez M, Gallardo A, Sanchez C, et al. Value of bronchial reversibility to salbutamol, exhaled nitric oxide and responsiveness to methacholine to corroborate the diagnosis of asthma in children. Allergol Immunopathol (Madr). 2020;48(3):214–22. https://doi. org/10.1016/j.aller.2019.11.001

Abstract 162 | PDF Downloads 148 XML Downloads 1 HTML Downloads 12

References

1. Mallol J, Riquelme C, Aguirre V, Martinez M, Gallardo A, Sanchez C, et al. Value of bronchial reversibility to salbutamol, exhaled nitric oxide and responsiveness to methacholine to corroborate the diagnosis of asthma in children. Allergol Immunopathol (Madr). 2020;48(3):214–22. https://doi. org/10.1016/j.aller.2019.11.001

2. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68. https://doi.org/10.1183 /09031936.05.00035205

3. Waalkens HJ, Merkus PJ, van Essen-Zandvliet EE, Brand PL, Gerritsen J, Duiverman EJ, et al. Assessment of bronchodi-lator response in children with asthma. Dutch CNSLD Study Group. Eur Respir J. 1993;6(5):645–51.

4. Masekela R, Gray D, Verwey C, Halkas A, Jeena PM. Paediatric spirometry guideline of the South African Thoracic Society: Part 1. S Afr Med J. 2013;103(12 Suppl 2):1036–41. https://doi. org/10.7196/SAMJ.7239

5. Mahut B, Bokov P, Delclaux C. Abnormalities of plethysmographic lung volumes in asthmatic children. Respir Med. 2010;104(7):966–71. https://doi.org/10.1016/j.rmed. 2010.01.015

6. Dufetelle E, Mulier G, Taytard J, Boizeau P, Le Roux E, Beydon N. Peripheral obstruction without airflow limitation is rare and not specific to asthma in children. Pediatr Pulmonol. 2020;n/a:(n/a). https://doi.org/10.1002/ppul.25222

7. Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O’Byrne PM. The global initiative for asthma (GINA): 25 years later. Eur Respir J. 2019;54(2). https://doi. org/10.1183/13993003.00598-2019

8. GRAPP (Research Group on Advances in Pediatric Pneumology). Pulmonary function tests for the assessment and monitoring of asthma in children above 3 years of age. Rev Mal Respir. 2003;20:638–43.

9. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. 2019. Available from: https:// www.sign.ac.uk/media/1773/sign158-updated.pdf (Last visit 3 January 2021).

10. GINA (Global Initiative for Asthma). Global strategy for asthma management and prevention. 2020. Available from: https:// ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf (Last visit 3 January 2021).

11. NAEPP (National Asthma Education and Prevention Program). Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94. https://doi.org/10.1016/j. jaci.2007.09.029

12. Ben Saad H. Promoting the inclusion of lung volumes in the reversibility evaluation. Respir Care. 2017;62(2):255–6. https://doi.org/10.4187/respcare.05277

13. Saad HB, Préfaut C, Tabka Z, Zbidi A, Hayot M. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD. Pulm Pharmacol Ther. 2008;21(5):767–73. https://doi.org/10.1016/j.pupt.2008.04.005

14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38. https://doi.org/10.2147/COPD.S127336

15. Torén K, Bake B, Olin AC, Engström G, Blomberg A, Vikgren J, et al. Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study. Int J Chron Obstruct Pulmon Dis. 2017;12:973–80. https://doi.org/10.2147/COPD.S127336

16. Guezguez F, Ben Saad H. What constitutes a “clinically significant” bronchodilator response in children? Eur Respir J. 2020;55(5). https://doi.org/10.1183/13993003.00207-2020